Chemotherapy for local treatment of bladder cancer

Seminars in Radiation Oncology

Volumn 15, Issue 1, 2005, Pages 60-65

  Sternberg, Cora N ^a  

^a S Camillo Forlanini H ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; EPIRUBICIN; METHOTREXATE; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; BLADDER CANCER; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL TRIAL; CYSTECTOMY; FOLLOW UP; HUMAN; KIDNEY PRESERVATION; MEDICAL DOCUMENTATION; PRIORITY JOURNAL; REVIEW; STATISTICAL SIGNIFICANCE;

EID: 12344265542     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2004.07.014     Document Type: Article

References (49)

1. J.P. Stein, G. Lieskovsky, R. Cote, S. Groshen, A.C. Feng, S. Boyd Radical cystectomy in the treatment of invasive bladder cancer long-term results in 1054 patients J Clin Oncol 19 3 2001 666 675
2. G. Dalbagni, E. Genega, M. Hashibe, Z.F. Zhang, P. Russo, H. Herr Cystectomy for bladder cancer a contemporary series J Urol 165 4 2001 1111 1116
3. P. Bassi, G.D. Ferrante, N. Piazza, R. Spinadin, R. Carando, G. Pappagallo Prognostic factors of outcome after radical cystectomy for bladder cancer a retrospective study of a homogeneous patient cohort J Urol 161 5 1999 1494 1497
4. M.A. Ghoneim, M.M. el-Mekresh, M.A. el-Baz, I.A. el-Attar, A. Ashamallah Radical cystectomy for carcinoma of the bladder critical evaluation of the results in 1,026 cases J Urol 158 2 1997 393 399
5. C.N. Sternberg Current perspectives in muscle invasive bladder cancer Eur J Cancer 38 4 2002 460 467
6. C.N. Sternberg, V. Pansadoro, F. Calabrò, S. Schnetzer, D. Giannarelli, P. Emiliozzi Can patient selection for bladder preservation be based on response to chemotherapy? Cancer 97 7 2003 1644 1652
7. H.W. Herr, H.I. Scher Surgery of invasive bladder cancer is pathologic staging necessary? Sem Oncol 17 1990 590 597
8. International collaboration of trialists Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer a randomised controlled trial Lancet 354 9178 1999 533 540
9. H.B. Grossman, R.B. Natale, C.M. Tangen, V.O. Speights, N.J. Vogelzang, D.L. Trump Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer N Engl J Med 349 9 2003 859 866
10. H.B. Grossman, R.B. Natale, C.M. Tangen, V.O. Speights, N.J. Vogelzang, D.L. Trump Errata Corrige for: "Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer" published in N Engl J Med 2003 Aug 28;349(9):859-866 N Engl J Med 349 9 2003 1880
11. R.R. Hall Updated results of a randomised controlled trial of neoadjuvant cisplatin (C), methotrexate (M) and vinblastine (V) chemotherapy for muscle-invasive bladder cancer Proc Annu Meet Am Soc Clin Oncol 21 1 2002 178a
12. P. Bassi, F. Pagano, G. Pappagallo, S. Cosciani, A. Lembo, G. Anselmo, P. Sperandio, G. Signorelli, F. Di Tonno, E. Hurwitz, D. Lavelli, M. Seren, N. Piazza, L. Faggiano, M. Fiorentino Neo-adjuvant M-VAC of invasive bladder cancer The G.U.O.N.E. multicenter phase III trial Eur Urol 33 Suppl. 1 1998 142
13. P.U. Malmstrom, E. Rintala, R. Wahlqvist, P. Hellstrom, S. Hellsten, E. Hannisdal Five year follow-up of a prospective trial of radical cystectomy and neoadjuvant chemotherapy J Urol 155 1996 1903 1906
14. A. Sherif, E. Rintala, O. Mestad, J. Nilsson, L. Holmberg, S. Nilsson Neoadjuvant cisplatin-methotrexate chemotherapy of invasive bladder cancer--nordic cystectomy trial 2 Scand J Urol Nephrol 36 6 2002 419 425
15. A. Sherif, E. Rintala, O. Mestad, J. Nilsson, L. Holmberg, S. Nilsson, P.U. Malmstrom Neoadjuvant Platinum based combination chemotherapy improves overall survival in patients with locally advanced bladder cancer A meta-analysis of two nordic collaborative studies of 620 patients J Urol 169 2003 307
16. C.N. Sternberg, M.K.B. Parmar Neo-adjuvant chemotherapy is not (yet) standard treatment for muscle invasive bladder cancer J Clin Oncol 19 Suppl. 1 2001 21S-26S
17. Advanced Bladder Cancer Meta-analysis Collaboration Neoadjuvant chemotherapy in invasive bladder cancer a systematic review and meta-analysis Lancet 361 9373 2003 1927 1934
18. H.W. Herr, D.F. Bajorin, H.I. Scher Neoadjuvant chemotherapy and bladder sparing surgery for invasive bladder cancer ten-year outcome J Clin Oncol 16 4 1998 1298 1301
19. Radiation Therapy Oncology Group W.U. Shipley, D.S. Kaufman, W.J. Tester, M.V. Pilepich, H.M. Sandler Overview of bladder cancer trials in the Radiation Therapy Oncology Group Cancer 97 8 Suppl. 2003 2115 2119
20. R. Millikan, C. Dinney, D. Swanson, P. Sweeney, J.Y. Ro, T.L. Smith Integrated therapy for locally advanced bladder cancer final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC J Clin Oncol 19 2001 4005 4013
21. R. Sauer, S. Birkenhake, R. Kühn, C. Wittekind, P. Martus, J. Dunst Muscle-invasive bladder cancer transurethral resection and radiochemotherapy as an organ-sparing treatment option Z. Petrovich L. Baert L.W. Brady Carcinoma of the Bladder 1998 Springer-Verlag New York, NY: Berlin 205 214
22. M. Housset, B. Dufour, C. Maulard-Durdux, Y. Chretien, A. Mejean Concomitant fluorouracil (5-FU)-cisplatin (CDDP) and bifractionated split course radiation therapy (BSCRT) for invasive bladder cancer Proc Am Soc Clin Oncol 16 1997 319A
23. C.N. Sternberg Neo-adjuvant and adjuvant chemotherapy of bladder cancer is there a role? Ann Oncol 13 Suppl. 4 2002 273 279
24. F. de Braud, M. Maffezzini, V. Vitale, P. Bruzzi, G. Gatta, W.F. Hendry Bladder cancer Crit Rev Oncol Hematol 41 1 2002 89 106
25. D.G. Skinner, J.R. Daniels, C.A. Russell, G. Lieskovsky, S.D. Boyd, P. Nichols The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer a prospective comparative trial J Urol 145 1991 459 467
26. M. Stockle, W. Meyenburg, S. Wellek, G. Voges, U. Gertenbach, J.W. Thuroff Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2) improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy results of a controlled prospective study J Urol 148 1992 302 307
27. M. Stockle, W. Meyenburg, S. Wellek Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited long term results of a controlled prospective study and further clinical experience J Urol 153 1995 47 52
28. T. Otto, C. Börgemann, S. Krege, H. Rübben, R. Hartung, K. Haubensak, K. Henning, L. Hertle, D. Jocham, D. Kröpfl, J. Rassweiler, S. Roth, R. Tauber, R. Tschada, L. Weissbach Adjuvant chemotherapy in locally advanced bladder cancer (PT3/PN1-2,M0)--A Phase III Study Eur Urol 39 Suppl. 5 2001 147
29. R. Sylvester, C. Sternberg The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer what we do not know and why Ann Oncol 11 7 2000 851 856
30. C.N. Sternberg, A. Yagoda, H.I. Scher, R.C. Watson, N. Geller, H.W. Herr M-VAC for advanced transitional cell carcinoma of the urothelium Efficacy, and patterns of response and relapse Cancer 64 1989 2448 2458
31. C.N. Sternberg, P.H.M. de Mulder, J.H. Schornagel, C. Théodore, S.D. Fossa, A.T. van Oosterom Randomized Phase III Trial of high dose intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors European Organization for Research and Treatment of Cancer Protocol No. 30924. J Clin Oncol 19 10 2001 2638 2646
32. H. von der Maase, S.W. Hansen, J.T. Roberts, L. Dogliotti, T. Oliver, M.J. Moore Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer results of a large, randomized, multinational, multicenter, phase III study J Clin Oncol 18 17 2000 3068 3077
33. R.J. Cote, D. Esrig, S. Groshen, P.A. Jones, D.G. Skinner p53 and treatment of bladder cancer Nature 385 6612 1997 123 125
34. R.J. Cote, M.D. Dunn, S.J. Chatterjee, J.P. Stein, S.R. Shi, Q.C. Tran Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53 Cancer Res 58 6 1998 1090 1094
35. S.G. Williams, R. Gandour-Edwards, A.D. Deitch, S. Toscano, J.J. Fan, C.N. Sternberg Differences in gene expression in muscle-invasive bladder cancer a comparison of Italian and American patients Eur Urol 39 4 2001 430 437
36. L.M. McShane, R. Aamodt, C. Cordon-Cardo, R. Cote, D. Faraggi, Y. Fradet Reproducibility of p53 immunohistochemistry in bladder tumors National Cancer Institute, Bladder Tumor Marker Network Clin Cancer Res 6 5 2000 1854 1864
37. D.M. Wallace, D. Raghavan, K.A. Kelly, T.F. Sandeman, I.G. Conn, N. Teriana Neo-adjuvant (pre-emptive) cisplatin therapy in invasive transitional cell carcinoma of the bladder Br J Urol 67 1991 608 615
38. C.M. Coppin, M.K. Gospodarowicz, K. James Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation The National Cancer Institute of Canada Clinical Trials Group J Clin Oncol 14 11 1996 2901 2907
39. J.A. Martinez Pineiro, M. Gonzalez Martin, F. Arocena Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder prospective randomized phase III study J Urol 153 1995 964 973
40. R.B. Natale, H.B. Grossman, B. Blumenstein, N. Vogelzang, D.L. Trump, V.O. Speights, R. de Vere White, E.D. Crawford SWOG 8710 (INT-0080) randomized phase III trial of neoadjuvant M-VAC and cystectomy versus cystectomy alone in patients with locally advanced bladder cancer Proc Am Soc Clin Oncol 20 1 2001 2a
41. GISTV (Italian Bladder Cancer Study Group). Neoadjuvant treatment for locally advanced bladder cancer a randomized prospective clinical trial J Chemother 8 1996 345 346
42. M. Orsatti, A. Curotto, L. Canobbio Alternating chemo-radiotherapy in bladder cancer a conservative approach Int J Radiation Oncol Biol Phys 33 1995 173 178
43. H. Abol-Enein, M. El Makresh, M. El Baz, M. Ghoneim Neo-adjuvant chemotherapy in treatment of invasive transitional bladder cancer a controlled, prospective randomised study Br J Urol 80 Suppl. 2 1997 49
44. W. Tester, A. Porter, S. Asbell Combined modality program with possible organ preservation for invasive bladder carcinoma results of RTOG protocol 85-12 Int J Radiat Oncol Biol Phys 25 1993 783 790
45. W. Tester, R. Caplan, J. Heaney Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer results of Radiation Therapy Oncology Group phase II trial 8802 J Clin Oncol 14 1 1996 119 126
46. W.U. Shipley, K.A. Winter, D.S. Kaufman, W.R. Lee, N.M. Heney, W.R. Tester Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy initial results of Radiation Therapy Oncology Group 89-03 J Clin Oncol 16 11 1998 3576 3583
47. R. Sauer, C. Rodel Biological selection for organ conservation Eur J Cancer 37 Suppl. 6 2001 S286
48. C. Durdux, M. Housset, B. Dufour Altered fractionation in chemo-radiation for bladder cancer Eur J Cancer 37 Suppl. 6 2001 S286
49. W.U. Shipley, D.S. Kaufman, E. Zehr, N.M. Heney, S.C. Lane, H.K. Thakral Selective bladder preservation by combined modality protocol treatment long-term outcomes of 190 patients with invasive bladder cancer Urol 60 1 2002 62 67